NCT00101179 2019-10-18MS-275 and Azacitidine in Treating Patients With Myelodysplastic Syndromes, Chronic Myelomonocytic Leukemia, or Acute Myeloid LeukemiaNational Cancer Institute (NCI)Phase 1 Completed63 enrolled